Clinical Trials Browser

Phase NA × Lymphoma, B-Cell, Marginal Zone × Arsenic Trioxide × Clear all

NCT00005786 2013-02-01

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, B-Cell, Marginal Zone